Williamson v. Genentech, Inc.

United States District Court for the Northern District of California

Williamson v. Genentech, Inc.

Trial Court Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 ANDREW WILLIAMSON, et al., Case No. 20-cv-06695-JSC

8 Plaintiffs, ORDER REMANDING ACTION TO 9 v. STATE COURT FOR LACK OF SUBJECT MATTER JURISDICTION 10 GENENTECH, INC., et al., Defendants. 11

12 13 Plaintiffs challenge Genentech’s sale of prescription drugs in single-dose vials under 14 California’s Unfair Competition Law (UCL), California Business and Professions Code § 17200. 15 The Court previously remanded the action for lack of subject matter jurisdiction because Plaintiff 16 Andrew Williamson, who alleged that Genentech’s use of single-dose vials resulted in waste, 17 failed to demonstrate Article III standing as he had not alleged a concrete injury. Williamson then 18 joined his insurer, Blue Cross Blue Shield of Kansas City as a plaintiff, and Genentech again 19 removed the action to this Court under the Class Action Fairness Act. Genentech then moved to 20 dismiss the Third Amended Complaint as preempted by federal law, barred by California’s 21 judicial-abstention doctrine, and for failure to state a claim.1 (Dkt. No. 19.) While that motion was 22 under submission, Plaintiff Blue Cross Blue Shield of Kansas City filed a notice of voluntary 23 dismissal leaving Mr. Williamson as the sole plaintiff. (Dkt. No. 39.) The Court thereafter issued 24 an Order to Show Cause as to why the action should not again be remanded to state court because 25 Mr. Williamson, the sole remaining plaintiff, still lacks Article III standing. (Dkt. No. 40.) 26 Neither party responded to the Court’s Order. For the reasons stated below, the Court lacks 27 1 subject matter jurisdiction over this action and REMANDS the action to state court. 2 “[C]ourts have an ‘independent obligation’ to police their own subject matter jurisdiction, 3 including the parties’ standing.” Animal Legal Def. Fund v. United States Dep’t of Agric., 935

4 F.3d 858

, 866 (9th Cir. 2019) (citations omitted). To do so, the court must assure itself that 5 “Plaintiffs have alleged an injury in fact, fairly traceable to the defendant’s conduct, and likely to 6 be redressed by a favorable judicial decision.” Id. (citing Spokeo, Inc., v. Robins, ––– U.S. ––––, 7

136 S. Ct. 1540, 1547

(2016)). “Demonstrating injury in fact requires a plaintiff to show []he 8 suffered ‘an invasion of a legally protected interest’ that is ‘concrete and particularized’ and 9 ‘actual or imminent, not conjectural or hypothetical.’” Animal Legal Def. Fund, 935 F.3d at 866 10 (quoting Spokeo,

136 S. Ct. at 1548

). A “particularized” injury is one that affects the plaintiff 11 personally, and a “concrete” injury “must actually exist.” Animal Legal Def. Fund, 935 F.3d at 12 866. 13 The Court previously held Mr. Williamson did not have standing because he had not 14 alleged facts that supported an inference that the amount he paid for his Rituxan treatment would 15 have been reduced if Genentech had offered lower dosage vials and therefore, he had not suffered 16 a concrete injury. (Case No. 19-1840 JSC, Dkt. No. 64.) Mr. Williamson still admits—as he did 17 before—that the amount of money he paid out-of-pocket would not have changed even if the 18 amount of wasted medicine had been reduced. (Dkt. No. 23-4 at 33:23-34:2.) His attempt to save 19 his claim by arguing that even if he cannot seek restitution he can seek injunctive relief under 20 Section 17204 (id. at 34) is unavailing. Injunctive relief is only available to “a person who has 21 suffered injury in fact and has lost money or property as a result of the unfair competition.” Cal. 22 Bus. & Prof. Code § 17204. Mr. Williamson admits that he has not lost money or property as a 23 result of Genentech’s conduct. Further, Mr. Williamson has no standing to challenge the dosage 24 amount Genentech offers for any drug other than Rituxan given that he alleges that he was 25 prescribed and took only Rituxan and not one of the other three drugs challenged in this action. 26 (Dkt. No. 1-2 at ¶¶ 99-105.) 27 // 1 Accordingly, this action is REMANDED to the San Mateo County Superior Court based 2 || on lack of subject matter jurisdiction. 3 IT IS SO ORDERED. 4 || Dated: July 28, 2021 5 6 ne JACQUELINE SCOTT CORLE 7 United States Magistrate Judge 8 9 10 11 12

13

© 15 16

= 17

Z 18 19 20 21 22 23 24 25 26 27 28

Reference

Status
Unknown